Funding for TB and Neglected Disease Research Must Increase to Realize Promise of New Technologies
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected […]
News
Historically Successful Global Access Campaign for Pretomanid and BPaL-based Regimens Continues with Major Milestones in BRICS Countries
Throughout 2024, one of TB Alliance’s foremost priorities has been ensuring that pretomanid and BPaL-based regimens reach all people with
TB Alliance Joins Indonesia’s High-Level Meeting on TB
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
TB Alliance Appoints Srishti Gupta and Akshay Vaishnaw as New Members to its Board of Directors
NEW YORK (December 9, 2024)—TB Alliance welcomes Srishti Gupta, MD, MPP, MPhil, and Akshay Vaishnaw, MB, BCh, PhD, FRCP, to
TB Alliance Applauds WHO Prequalification of Macleods Pretomanid Product
NEW YORK (November 6, 2024) — Macleods, a pharmaceutical company headquartered in India, has received prequalification from the World Health
TB Alliance Awarded $7.35 Million by U.S. Department of Defense for Novel Tuberculosis Interventions
New York (October 7, 2024) – TB Alliance is proud to announce a $7.35 million award through the U.S. Department
Brazil and Philippines Accelerate Availability of Shorter Drug-Resistant Tuberculosis Treatment
MANILA (September 3, 2024) – A delegation of experts from Brazil’s National TB Program visited Manila recently to collaborate with
New Clinical Trial Examines Use of Novel Compound Telacebec in Buruli Ulcer Patients
NEW YORK (August 21, 2024) – In July 2024, a Phase 2 proof-of-concept study was initiated to explore the use
Ann E. Taylor, MD Joins the TB Alliance Board of Directors
NEW YORK (August, 15, 2024)—TB Alliance is honored to appoint Ann Taylor, MD to its Board of Directors. Welcoming Dr.
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
MANILA (25 March 2024)—TB Alliance’s new Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub launched today in Manila, with funding